On the other hand, GIGD as the integrated glucose handling capacity encompassing the glucagon inhibitory effect decreases with worsening glucose intolerance and increasing obesity, which may be a common pathophysiologic characteristic between Asians and Caucasians. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.